| |
control group
(benign) |
study group-1
(suspicious) |
study group-2
(malignant) |
sensitivity |
Specificity |
| Cytomorphology |
26 |
37 |
37 |
52.11% |
89.65% |
| Cytokeratin |
| Nuclear |
- |
- |
- |
91.89% |
89.5% |
| Cytoplasmic |
- |
29 |
32 |
| both |
- |
3 |
4 |
| |
|
32 |
36 |
| EMA |
| cytoplasmic |
- |
28 |
28 |
90.5% |
86.6% |
| membranous |
- |
3 |
3 |
| both |
- |
1 |
4 |
| Calretinin |
| Only nuclear |
- |
- |
- |
97% |
|
| Only cytoplasmic |
24 |
33 |
37 |
| both |
2 |
1 |
- |
|
